Landscape of the relationship between type 2 diabetes and coronary heart disease through an integrated gene network analysis

Gene

Volumn 539, Issue 1, 2014, Pages 30-36

  Dong, Changzheng ^a   Tang, Linlin ^a   Liu, Zhifang ^a   Bu, Shizhong ^a   Liu, Qiong ^a   Wang, Qinwen ^a   Mai, Yifeng ^a   Wang, Dao Wen ^b   Duan, Shiwei ^a  

^a NINGBO UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Coronary artery disease; Genome wide association; Hub; Network analysis; Pathway; Protein protein interaction; Type 2 diabetes

Indexed keywords

CORONARY ARTERY DISEASE; GENOME-WIDE ASSOCIATION; HUB; NETWORK ANALYSIS; PATHWAY; PROTEIN-PROTEIN INTERACTION; TYPE 2 DIABETES;

A KINASE ANCHOR PROTEINS; ACTIN CYTOSKELETON; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CALCIUM SIGNALING; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FOCAL ADHESIONS; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MAP KINASE SIGNALING SYSTEM; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN INTERACTION MAPPING; PROTO-ONCOGENE PROTEINS; SMAD3 PROTEIN;

EID: 84894357984     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.02.001     Document Type: Article

References (41)

1. Angelakopoulou A., Shah T., Sofat R., Shah S., Berry D.J., Cooper J., et al. Comparative analysis of genome-wide association studies signals for lipids, diabetes, and coronary heart disease: Cardiovascular Biomarker Genetics Collaboration. European Heart Journal 2012, 33:393-407.
2. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M. Gene Ontology: tool for the unification of biology. Nature Genetics 2000, 25:25-29.
3. Baccarelli A., Ghosh S. Environmental exposures, epigenetics and cardiovascular disease. Current Opinion in Clinical Nutrition and Metabolic Care 2012, 15:323-329.
4. Bader G.D., Donaldson I., Wolting C., Ouellette B.F., Pawson T., Hogue C.W. BIND-The Biomolecular Interaction Network Database. Nucleic Acids Research 2001, 29:242-245.
5. Cai E.P., Casimir M., Schroer S.A., Luk C.T., Shi S.Y., Choi D., et al. In vivo role of focal adhesion kinase in regulating pancreatic beta-cell mass and function through insulin signaling, actin dynamics, and granule trafficking. Diabetes 2012, 61:1708-1718.
6. Chaoxin J., Daili S., Yanxin H., Ruwei G., Chenlong W., Yaobin T. The influence of angiotensin-converting enzyme 2 gene polymorphisms on type 2 diabetes mellitus and coronary heart disease. European Review for Medical and Pharmacological Sciences 2013, 17:2654-2659.
7. Charoenboon C., Srisupundit K., Tongsong T. Rise in cesarean section rate over a 20-year period in a public sector hospital in northern Thailand. Archives of Gynecology and Obstetrics 2013, 287:47-52.
8. Chaudhary R., Likidlilid A., Peerapatdit T., Tresukosol D., Srisuma S., Ratanamaneechat S., et al. Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease. Cardiovascular Diabetology 2012, 11:36.
9. Chiha M., Njeim M., Chedrawy E.G. Diabetes and coronary heart disease: a risk factor for the global epidemic. International Journal of Hypertension 2012, 2012:697240.
10. Dastani Z., Hivert M.F., Timpson N., Perry J.R., Yuan X., Scott R.A., et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genetics 2012, 8:e1002607.
11. Duan S., Luo X., Dong C. Identification of susceptibility modules for coronary artery disease using a genome wide integrated network analysis. Gene 2013, 531:347-354.
12. Famula T.R., Oberbauer A.M., Sousa C.A. Complex segregation analysis of deafness in Dalmatians. American Journal of Veterinary Research 2000, 61:550-553.
13. Ho J.S., Germer S., Tam C.H., So W.Y., Martin M., Ma R.C., et al. Association of the PPARG Pro12Ala polymorphism with type 2 diabetes and incident coronary heart disease in a Hong Kong Chinese population. Diabetes Research and Clinical Practice 2012, 97:483-491.
14. Ideker T., Ozier O., Schwikowski B., Siegel A.F. Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 2002, 18(Suppl. 1):S233-S240.
15. Imamura M., Maeda S. Genetics of type 2 diabetes: the GWAS era and future perspectives [Review]. Endocrine Journal 2011, 58:723-739.
16. Jia P., Zheng S., Long J., Zheng W., Zhao Z. dmGWAS: dense module searching for genome-wide association studies in protein-protein interaction networks. Bioinformatics 2011, 27:95-102.
17. Kalwat M.A., Thurmond D.C. Signaling mechanisms of glucose-induced F-actin remodeling in pancreatic islet beta cells. Experimental & Molecular Medicine 2013, 45:e37.
18. Kanehisa M., Goto S., Furumichi M., Tanabe M., Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Research 2010, 38:D355-D360.
19. Kaur R., Matharoo K., Arora P., Bhanwer A.J. Association of -2518A>G promoter polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene with type 2 diabetes and coronary artery disease. Genetic Testing and Molecular Biomarkers 2013, 17:750-755.
20. Keshava Prasad T.S., Goel R., Kandasamy K., Keerthikumar S., Kumar S., Mathivanan S., et al. Human Protein Reference Database -2009 update. Nucleic Acids Research 2009, 37:D767-D772.
21. Lee Y., Li H., Li J., Rebman E., Achour I., Regan K.E., et al. Network models of genome-wide association studies uncover the topological centrality of protein interactions in complex diseases. Journal of the American Medical Informatics Association 2013, 20:619-629.
22. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
23. Matthews L., Gopinath G., Gillespie M., Caudy M., Croft D., de Bono B., et al. Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Research 2009, 37:D619-D622.
24. McPherson R. From genome-wide association studies to functional genomics: new insights into cardiovascular disease. The Canadian Journal of Cardiology 2013, 29:23-29.
25. Murea M., Ma L., Freedman B.I. Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. The Review of Diabetic Studies 2012, 9:6-22.
26. Ozgur A., Vu T., Erkan G., Radev D.R. Identifying gene-disease associations using centrality on a literature mined gene-interaction network. Bioinformatics 2008, 24:i277-i285.
27. Palomer X., Salvado L., Barroso E., Vazquez-Carrera M. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy. International Journal of Cardiology 2013, 168:3160-3172.
28. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics 2007, 81:559-575.
29. Rahimi Z., Nourozi-Rad R., Parsian A. Strong interaction between T allele of endothelial nitric oxide synthase with B1 allele of cholesteryl ester transfer protein TaqIB highly elevates the risk of coronary artery disease and type 2 diabetes mellitus. Human Genomics 2012, 6:20.
30. Saely C.H., Drexel H. Is type 2 diabetes really a coronary heart disease risk equivalent?. Vascular Pharmacology 2013, 59:11-18.
31. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research 2003, 13:2498-2504.
32. Tan C.K., Leuenberger N., Tan M.J., Yan Y.W., Chen Y., Kambadur R., et al. Smad3 deficiency in mice protects against insulin resistance and obesity induced by a high-fat diet. Diabetes 2011, 60:464-476.
33. Tarcea V.G., Weymouth T., Ade A., Bookvich A., Gao J., Mahavisno V., et al. Michigan molecular interactions r2: from interacting proteins to pathways. Nucleic Acids Research 2009, 37:D642-D646.
34. Torkamani A., Topol E.J., Schork N.J. Pathway analysis of seven common diseases assessed by genome-wide association. Genomics 2008, 92:265-272.
35. van Setten J., Isgum I., Smolonska J., Ripke S., de Jong P.A., Oudkerk M., et al. Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarction. Atherosclerosis 2013, 228:400-405.
36. Wang K., Li M., Bucan M. Pathway-based approaches for analysis of genomewide association studies. American Journal of Human Genetics 2007, 81:1278-1283.
37. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678.
38. Winnik S., Stein S., Matter C.M. SIRT1 - an anti-inflammatory pathway at the crossroads between metabolic disease and atherosclerosis. Current Vascular Pharmacology 2012, 10:693-696.
39. Yu W., Clyne M., Khoury M.J., Gwinn M. Phenopedia and Genopedia: disease-centered and gene-centered views of the evolving knowledge of human genetic associations. Bioinformatics 2010, 26:145-146.
40. Yuan Z., Miyoshi T., Bao Y., Sheehan J.P., Matsumoto A.H., Shi W. Microarray analysis of gene expression in mouse aorta reveals role of the calcium signaling pathway in control of atherosclerosis susceptibility. American Journal of Physiology. Heart and Circulatory Physiology 2009, 296:H1336-H1343.
41. Zhang X., Xu X., Jiao X., Wu J., Zhou S., Lv X. The effects of glucose fluctuation on the severity of coronary artery disease in type 2 diabetes mellitus. Journal of Diabetes Research 2013, 2013:576916.